Xcell Therapeutics recorded a single insider purchase during the past ninety days. Jeong Hae min acquired shares valued at 68.23 million KRW on October 20, 2026. This transaction occurred amid a thirteen percent decline in stock price over the same period, despite no recent earnings report being available for context.